Pacific Center for Financial Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.35K | Hold |
115
| – | – | ﹤0.01% | 370 |
|
|
2025
Q4 | $4.96K | Hold |
115
| – | – | ﹤0.01% | 374 |
|
|
2025
Q3 | $4.96K | Hold |
115
| – | – | ﹤0.01% | 374 |
|
|
2025
Q2 | $4.42K | Hold |
115
| – | – | ﹤0.01% | 364 |
|
|
2025
Q1 | $4.46K | Hold |
115
| – | – | ﹤0.01% | 361 |
|
|
2024
Q4 | $3.89K | Hold |
115
| – | – | ﹤0.01% | 382 |
|
|
2024
Q3 | $4.7K | Hold |
115
| – | – | ﹤0.01% | 368 |
|
|
2024
Q2 | $4.43K | Hold |
115
| – | – | ﹤0.01% | 362 |
|
|
2024
Q1 | $4.93K | Hold |
115
| – | – | ﹤0.01% | 367 |
|
|
2023
Q4 | $4.26K | Hold |
115
| – | – | ﹤0.01% | 320 |
|
|
2023
Q3 | $4.17K | Hold |
115
| – | – | ﹤0.01% | 333 |
|
|
2023
Q2 | $4.1K | Hold |
115
| – | – | ﹤0.01% | 328 |
|
|
2023
Q1 | $4.09K | Buy |
+115
| New | +$4.02K | ﹤0.01% | 325 |
|
|
2022
Q3 | $3K | Hold |
115
| – | – | ﹤0.01% | 342 |
|
|
2022
Q2 | $6K | Buy |
115
+1
| +0.9% | +$55 | ﹤0.01% | 314 |
|
|
2022
Q1 | $6K | Buy |
114
+2
| +2% | +$109 | ﹤0.01% | 306 |
|
|
2021
Q4 | $6K | Buy |
112
+2
| +2% | +$104 | ﹤0.01% | 313 |
|
|
2021
Q3 | $5K | Hold |
110
| – | – | ﹤0.01% | 324 |
|
|
2021
Q2 | $5K | Buy |
110
+3
| +3% | +$144 | ﹤0.01% | 296 |
|
|
2021
Q1 | $5K | Buy |
107
+1
| +0.9% | +$45 | ﹤0.01% | 285 |
|
|
2020
Q4 | $5K | Buy |
106
+1
| +1% | +$46 | ﹤0.01% | 276 |
|
|
2020
Q3 | $5K | Buy |
105
+2
| +2% | +$100 | ﹤0.01% | 247 |
|
|
2020
Q2 | $5K | Buy |
103
+1
| +1% | +$51 | ﹤0.01% | 236 |
|
|
2020
Q1 | $5K | Buy |
102
+1
| +1% | +$53 | ﹤0.01% | 223 |
|
|
2019
Q4 | $6K | Hold |
101
| – | – | ﹤0.01% | 243 |
|
|
2019
Q3 | $5K | Hold |
101
| – | – | ﹤0.01% | 256 |
|
|
2019
Q2 | $5K | Hold |
101
| – | – | ﹤0.01% | 253 |
|
|
2019
Q1 | $5K | Hold |
101
| – | – | ﹤0.01% | 252 |
|
|
2018
Q4 | $5K | Hold |
101
| – | – | ﹤0.01% | 247 |
|
|
2018
Q3 | $5K | Sell |
101
-20
| -17% | -$1.02K | ﹤0.01% | 256 |
|
|
2018
Q2 | $6K | Hold |
121
| – | – | ﹤0.01% | 229 |
|
|
2018
Q1 | $6K | Sell |
121
-123
| -50% | -$5.73K | ﹤0.01% | 230 |
|
|
2017
Q4 | $11K | Buy |
244
+123
| +102% | +$5.68K | 0.01% | 196 |
|
|
2017
Q3 | $6K | Hold |
121
| – | – | ﹤0.01% | 233 |
|
|
2017
Q2 | $7K | Hold |
121
| – | – | ﹤0.01% | 218 |
|
|
2017
Q1 | $6K | Hold |
121
| – | – | ﹤0.01% | 220 |
|
|
2016
Q4 | $6K | Buy |
+121
| New | +$5.98K | ﹤0.01% | 226 |
|
Other funds holding GSK
JEST
Pacific Center for Financial Services's GSK Position: Q1 2026 in Review
Pacific Center for Financial Services held its GSK (GSK) position steady in Q1 2026 at 115 shares worth $6.35K. The position accounts for ﹤0.01% of the portfolio, ranked #370.
Pacific Center for Financial Services first reported a position in GSK in Q4 2016 and has held it in 37 quarters since. The position peaked at $11K in Q4 2017. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Pacific Center for Financial Services held 115 shares of GSK worth $6.35K as of Q1 2026.
- Pacific Center for Financial Services left its GSK share count unchanged in Q1 2026.
- GSK made up ﹤0.01% of Pacific Center for Financial Services's portfolio in Q1 2026, its #370 holding.
- Pacific Center for Financial Services first reported a position in GSK in Q4 2016 and has held it in 37 quarters since.
- Pacific Center for Financial Services's GSK position peaked at $11K in Q4 2017.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Pacific Center for Financial Services's 13F filing for Q1 2026, filed 12 May 2026.